“Who is Abstergo?” is a multi-part series of articles that explores the past, present, and plans for the future of Abstergo. This series is being published to create an accurate public profile of the company, and to debunk the myths surrounding its creation and operations.
With all of Abstergo’s accomplishments and contributions to humanity, where could the company possibly go next? Well, we already know of three projects slated for launch by the end of this year! The first one to expect is the Animus 3.0 project, scheduled for launch on 30 October 2012. Animus 3.0 will feature an advanced synchronization engine to allow users to better explore their DNA memory and maintain stronger control over their physical actions while in-program. The upgraded software will also allow users to see more human interaction in their display.
The next is the Portable Animus, which doesn’t have an exact release date, but is anticipated for launch also in October 2012. The Portable Animus will have similar features and functions to Animus 3.0, but in a device that is portable. Advantages to this project include users’ ability to jump into their DNA memory as needed on the go.
Finally this year, Abstergo will be launching the EYE-ABSTERGO satellite into orbit on 21 December 2012. The purpose of EYE-ABSTERGO is to boost the functions of the ASP satellite, launched by Abstergo in 2008. Instead of having to route signals to centralized data hubs for distribution, EYE-ABSTERGO will allow signals to be sent directly to end users all around the planet, ensuring that data is sent securely and as fast as possible to those requesting.
Of course, Abstergo also plans to continue its core business in pharmaceutical research and development in an effort to create better treatments and formulate more cures. To quote Dr. Vidic in an internal document, “We change the world every day in a hundred different ways.” Be it pharmaceuticals, communications, or technology, Abstergo will be there to lead humanity forward.